REDUCING SUPPRESSIVE THERAPY IN PATIENTS WITH A HISTORY OF THYROID-CANCER

被引：0
|
作者：
BLUM, M
PERLMAN, S
机构：
来源：
ANNALS OF INTERNAL MEDICINE | 1995年 / 123卷 / 10期
关键词：
D O I：
10.7326/0003-4819-123-10-199511150-00016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：808 / 809
页数：2
相关论文
共 50 条
  • [1] PERIPHERAL THYROTOXICOSIS DURING SUPPRESSIVE TREATMENT OF THYROID-CANCER
    HESHMATI, HM
    LEENHARDT, L
    NOELWEKSTEIN, S
    JACOB, N
    PAYAN, C
    BLACKER, C
    AURENGO, A
    TURPIN, G
    PRESSE MEDICALE, 1992, 21 (33): : 1584 - 1584
  • [2] RADIONUCLIDES AND THERAPY OF THYROID-CANCER
    ODOHERTY, MJ
    NUNAN, TO
    CROFT, DN
    NUCLEAR MEDICINE COMMUNICATIONS, 1993, 14 (09) : 736 - 755
  • [3] SURGICAL THERAPY OF THYROID-CANCER
    WOLFF, H
    SCHIMPFLE, B
    ZENTRALBLATT FUR CHIRURGIE, 1989, 114 (18): : 1202 - 1208
  • [4] RADIOIODINE THERAPY FOR THYROID-CANCER
    SWEENEY, DC
    JOHNSTON, GS
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1995, 24 (04) : 803 - +
  • [5] CHRONIC SUPPRESSIVE THYROXINE THERAPY AND FOREARM, SPINAL AND HOP BONE-DENSITY IN 114 PATIENTS WITH THYROID-CANCER
    HAWKINS, F
    LOPEZ, MB
    RIGOPOULOU, D
    PAPAPIETRO, K
    GARCIA, L
    SARABIA, F
    ARNAIZ, F
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S252 - S252
  • [6] HIGHLY SENSITIVE DETERMINATION OF TSH IN THE FOLLOW-UP OF TSH-SUPPRESSIVE THERAPY OF PATIENTS WITH DIFFERENTIATED THYROID-CANCER
    MANN, K
    SALLER, B
    MEHL, U
    HORMANN, R
    MOSER, E
    NUKLEARMEDIZIN, 1988, 27 (01) : 24 - 28
  • [7] ACLACINOMYCIN THERAPY IN METASTASIZING THYROID-CANCER
    SAMONIGG, H
    FEREBERGER, W
    LEB, G
    BIFFL, E
    BLUT, 1983, 47 (03): : 175 - 176
  • [8] CANCER RISKS IN THYROID-CANCER PATIENTS
    HALL, P
    HOLM, LE
    LUNDELL, G
    BJELKENGREN, G
    LARSSON, LG
    LINDBERG, S
    TENNVALL, J
    WICKLUND, H
    BOICE, JD
    BRITISH JOURNAL OF CANCER, 1991, 64 (01) : 159 - 163
  • [9] DIAGNOSTIC-VALUE OF A SINGLE SERUM THYROGLOBULIN DETERMINATION ON AND OFF THYROID SUPPRESSIVE THERAPY IN THE FOLLOW-UP OF PATIENTS WITH DIFFERENTIATED THYROID-CANCER
    PACINI, F
    LARI, R
    MAZZEO, S
    GRASSO, L
    TADDEI, D
    PINCHERA, A
    CLINICAL ENDOCRINOLOGY, 1985, 23 (04) : 405 - 411
  • [10] OCTREOTIDE THERAPY IN ADVANCED THYROID-CANCER
    ZLOCK, DW
    GREENSPAN, FS
    CLARK, OH
    HIGGINS, CB
    THYROID, 1994, 4 (04) : 427 - 431
12345